Skip to main content
WH

WhiteLab Genomics

Paris, France
Last funding
$26.0M
Series BOct 2026

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

About WhiteLab Genomics

How much funding has WhiteLab Genomics raised?

WhiteLab Genomics has raised $26.0M in total funding. The most recent round was Series B. The last funding was announced in October 2026.

Who are WhiteLab Genomics's investors?

WhiteLab Genomics's investors include AVP, Y Combinator, Omnes Capital, Debiopharm Group, Blast. Club.

Where is WhiteLab Genomics headquartered?

WhiteLab Genomics is headquartered in Paris, France.

What does WhiteLab Genomics do?

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

What stage is WhiteLab Genomics at?

WhiteLab Genomics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"WhiteLab Genomics — Funding & Investors." VCBacked, October 5, 2026, https://www.vcbacked.co/company/whitelab-genomics. Accessed November 14, 2026.
APA
VCBacked. (2026). WhiteLab Genomics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/whitelab-genomics
Wikipedia (cite web)
{{cite web |title=WhiteLab Genomics — Funding & Investors |url=https://www.vcbacked.co/company/whitelab-genomics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at WhiteLab Genomics? Request a listing update

Founder contacts
m***@whitelabgx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →